Lane HC - Search Results

1

Progression of human immunodeficiency virus disease is associated with increasing disruptions within the CD4+ T cell receptor repertoire.

Gea-Banacloche JC, Weiskopf EE, Hallahan C, López Bernaldo de Quirós JC, Flanigan M, Mican JM, Falloon J, Baseler M, Stevens R, Lane HC, Connors M. Gea-Banacloche JC, et al. Among authors: lane hc. J Infect Dis. 1998 Mar;177(3):579-85. doi: 10.1086/514233. J Infect Dis. 1998. PMID: 9498435

2

A phase I study of interferon-alpha 2b in combination with interleukin-2 in patients with human immunodeficiency virus infection.

Schnittman SM, Vogel S, Baseler M, Lane HC, Davey RT Jr. Schnittman SM, et al. Among authors: lane hc. J Infect Dis. 1994 May;169(5):981-9. doi: 10.1093/infdis/169.5.981. J Infect Dis. 1994. PMID: 7909550 Clinical Trial.

3

Combination therapy with didanosine and interferon-alpha in human immunodeficiency virus-infected patients: results of a phase I/II trial.

Kovacs JA, Bechtel C, Davey RT Jr, Falloon J, Polis MA, Walker RE, Metcalf JA, Davey V, Piscitelli SC, Baseler M, Dewar R, Salzman NP, Masur H, Lane HC. Kovacs JA, et al. Among authors: lane hc. J Infect Dis. 1996 Apr;173(4):840-8. doi: 10.1093/infdis/173.4.840. J Infect Dis. 1996. PMID: 8603961 Clinical Trial.

4

Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1.

Walker RE, Spooner KM, Kelly G, McCloskey RV, Woody JN, Falloon J, Baseler M, Piscitelli SC, Davey RT Jr, Polis MA, Kovacs JA, Masur H, Lane HC. Walker RE, et al. Among authors: lane hc. J Infect Dis. 1996 Jul;174(1):63-8. doi: 10.1093/infdis/174.1.63. J Infect Dis. 1996. PMID: 8656014

5

Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons.

Davey RT Jr, Chaitt DG, Piscitelli SC, Wells M, Kovacs JA, Walker RE, Falloon J, Polis MA, Metcalf JA, Masur H, Fyfe G, Lane HC. Davey RT Jr, et al. Among authors: lane hc. J Infect Dis. 1997 Apr;175(4):781-9. doi: 10.1086/513971. J Infect Dis. 1997. PMID: 9086130

6

HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies.

Connors M, Kovacs JA, Krevat S, Gea-Banacloche JC, Sneller MC, Flanigan M, Metcalf JA, Walker RE, Falloon J, Baseler M, Feuerstein I, Masur H, Lane HC. Connors M, et al. Among authors: lane hc. Nat Med. 1997 May;3(5):533-40. doi: 10.1038/nm0597-533. Nat Med. 1997. PMID: 9142122

7

A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection.

Davey RT Jr, Chaitt DG, Albert JM, Piscitelli SC, Kovacs JA, Walker RE, Falloon J, Polis MA, Metcalf JA, Masur H, Dewar R, Baseler M, Fyfe G, Giedlin MA, Lane HC. Davey RT Jr, et al. Among authors: lane hc. J Infect Dis. 1999 Apr;179(4):849-58. doi: 10.1086/314678. J Infect Dis. 1999. PMID: 10068580 Clinical Trial.

8

Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression.

Kovacs JA, Imamichi H, Vogel S, Metcalf JA, Dewar RL, Baseler M, Stevens R, Adelsberger J, Lambert L, Davey RT Jr, Walker RE, Falloon J, Polis MA, Masur H, Lane HC. Kovacs JA, et al. Among authors: lane hc. J Infect Dis. 2000 Oct;182(4):1063-9. doi: 10.1086/315821. Epub 2000 Sep 5. J Infect Dis. 2000. PMID: 10979900 Clinical Trial.

9

Longitudinal changes in CD4+ T cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of HIV-infected patients.

Gea-Banacloche JC, Martino L, Mican JM, Hallahan CW, Baseler M, Stevens R, Lambert L, Polis M, Lane HC, Connors M. Gea-Banacloche JC, et al. Among authors: lane hc. AIDS Res Hum Retroviruses. 2000 Nov 20;16(17):1877-86. doi: 10.1089/08892220050195838. AIDS Res Hum Retroviruses. 2000. PMID: 11118073

10

A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.

Davey RT Jr, Davey VJ, Metcalf JA, Zurlo JJ, Kovacs JA, Falloon J, Polis MA, Zunich KM, Masur H, Lane HC. Davey RT Jr, et al. Among authors: lane hc. J Infect Dis. 1991 Jul;164(1):43-52. doi: 10.1093/infdis/164.1.43. J Infect Dis. 1991. PMID: 1676045 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

465 results

Search Page

Filters